This suggests that both CLL subtypes originate from self-reactive B cell precursors, and the degree of BCR polyreactivity—and consequently autoantigen recognition—correlates with the clinical course of the disease9. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.